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SUMMARY 
Twenty four patients meeting R.D.C criteria for schizopnrenia were assessed using the 
B.P.R.S. before starting neuroleptics. Tht\ were then given a standardized test dcse of 
haloperidol. Their subjective response to the test dose was assessed 4 hours later by a 
blind rater. The 1>.P.R.S. ratings were repeated after 3 weeks of neuroleptic treatment. A 
dysphoric response to the test dose was associated with a poor therapeutic outcome. The 
implications of these findings are discussed. 
There is considerable evidence to 
show that neuroleptic drugs are effective 
in the treatment of schizophrenia. How-
ever some patients do not respond well to 
drug treatment. Many efforts have been 
made to predict as to which patients will 
improve with treatment (Langfeldt, 1969; 
Itilet al., 1975; Seeman, 1985). No app-
roach has been uniformly successful. 
Singh and Smith (1973) made an interes-
ting observation that patients who be-
came 'high and happy' after starting hal-
operidol (euphoric responders) improved 
more with drug treatment than those who 
became 'anxious, tense and depressed' 
(dysphoric responders). These earlier 
findings were later Confirmed by Singh 
(1976) in a study on 18 schizophrenic 
patients. Dysphoric reactions to neuro-
leptics were measured on a 7 point scale. 
Most patients with a significant dysphoric 
response did not respond well to treat-
ment. 
Similar findings were also reported by 
Mayet al. (1976). Subjects were given a 
test dose and the subjective response was 
measured 4 hours later. The subjective 
response varied from highly negative to 
highly positive and correlated significantly 
with the clinical improvement (p<0 001). 
This work was extended further by 
Van Putten and May (1978). They ob-
served 42 newly admitted schizophrenic 
patients without drugs for 3-5 days. All 
were then given 2.2 mg/kg body weight of 
chlorpromazine. The subjective response 
was measured 4 hours later by a blind 
rater using a standardized questionnaire. 
The outcome was rated using the B P.R.S. 
Sixty percent of patients had an euphoric 
response and 40% had dysphoric response 
to the test dose. A significant correlation 
was seen between thesubjectiveresponse & 
clinical improvement- Dysphoric respon-
ses were associated with a worse outcome. 
Similar findings have been reported 
by workers from other countries, such as 
Canada (Hogan et al, 1985) and Hungary 
(Bartko et al., 1987). To the best of our 
knowledge no study of this nature has 
been done on Indian patients. This study 
aims to test the hypothesis that the sub-
jective response to a test dose of a neuro-
leptic can be used to predict the response 
to treatment in a group of Indian schizo-
phrenic patients. 
Material and Methods 
This study was performed in the 
Central Institute of Psychiatry, Ranchi 
•Consultant Psychiatrist, Davis Institute of Neuropsychiatry, Kankc, Ranchi. 
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from February to May, 1988. Thirty con-
secutive schizophrenic patients, meeting 
the inclusion criteria, who were admitted 
to the institute were taken up for the 
study. The inclusion criteria were : 
(a) R.D.G. criteria (Spitzer et al., 
1975) for schizophrenia. 
(b) Off drugs for atleast 2 weeks before 
admission. 
(c) Cooperative and gave consent for the 
study. 
Patients who had been given only 1 
or 2 doses of drugs before admission were 
kept drug free in the ward for 3 days and 
were then taken up for the study. The 
patients were assessed using the B.P.R.S. 
(Overall and Gorham, 1962) soon after 
admission, before they received any drugs. 
All the ratings were done by the first au-
thor The patients were then given a 
standardized test dose of haloperidol v0.05 
mg/kg of body weight). The drug was 
given in a liquid form making exact titra-
tion of the dose possible. 
Four hours after the test dose, the 
subjective response was assessed, using the 
standardized questionnaire of Van Putten 
and May (1978), by an independent blind 
rater who was not involved in the rest of 
the study. This consisted of 4 questions : 
(1) How does this medication agree with 
you? 
—unpleasant or bad effect. 
—pleasant, good or helpful effect. 
(2) Did it make you feel calmer? 
(3) Did it affect your thinking? 
(4) Do you think that this would be the 
right medication for you? 
Each question was scored on a scale 
ranging from +11 for a maximal positive 
response, 0 for no effect, to —11 for a 
maximal negative response. The subjec-
tive response questionnaires were sealed 
after completion and were opened only 
after the entire study had been completed. 
The patients were started on haloperidol 
after assessment of the subjective response. 
Male patients received 20 mg/day and 
female patients received 15 mg/day. The 
resident incharges of the patients were 
requested not to change the doses unless 
it was absolutely necessary. Antiparkin-
sonian drugs were given if required. 
None of the patients received E.G.T, 
The patients were re-assessed using 
the B.P.R.S. 3 weeks after starting neuro-
leptics. The change in scores was noted. 
The subjective responses were analyzed 
after all the B.P.R.S. ratings were comp-
leted- Those with a total subjective res-
ponse score less than or equal to 0 were 
classified as dysphoric responders. Those 
with a score greater than 0 were classified 
as syntonic responders. 
Results 
Thirty patients (24 males and 6 fe-
males) were taken up for the study. Six 
male patients had to be dropped from the 
study for the following reasons : 
(a) 3 patients were discharged before 
completion of the study. 
(b) 1 patient's diagnosis was revised due 
to new findings. 
(c) 1 patient developed a physical illness. 
(d) 1 patient later refused to cooperate 
for the study. 
Of the remaining 24 patients left in 
the study, 5 had a dysphoric response to 
the test dose and 19 had a syntonic res-
ponse. These 2 groups did not differ signi-
ficantly from caeh other with respect to 
age, duration of illness, initial B.P.R.S. 
scores or sex distribution (Table I). How-
ever, the reduction in B.P.R.S. scores 
with treatment was significantly less in 
the dysphoric group (p<0.05). 
Taking the entire sample (n = 24), the 
Pearson correlation coefficient between 
the subjective response scores and the 
change in the B.P.R.S. scores was highly 
significant (r=0.57, p<0.005). The corre-
lation between the duration of illness and 
the change in B.P.R.S. scores was also 60  MILIND BORDE etal. 
TABLE 1—Comparison of the Syntonic and Dysphoric Groups 
Mean age (in years) 
Mean length of illness (in years) 
Mean initial B.P.R.R.S. score 
Mean change in B.P.R.S. score 
Sex distribution 
Dy»phor 
Mean 
28. 8 
4. 2 
30.80 
5. 8 
ic group 
5) 
S.D. 
11.01 
4.13 
12.41 
7.12 
4 males 
1 female 
Syntonic group 
(n= 19) 
Mean 
31.05 
4.82 
35.84 
15.95 
S.D. 
6.28 
3.44 
7.24 
11.12 
14 males 
5 females 
'f 
0.60 
0.35 
1.19 
1.92 
Significance 
N.S. 
N.S. 
N.S. 
p<0.05 
Not significant 
d.f. =22 
significant (r=".36, p<0.05). 
There were no significant correlations 
between : 
(a) The subjective response scores and 
the initial B.P.R.S scores. 
(b) The change in B.P.R.S. scores and 
the current age or the age of onset 
of the illness. 
(c) The initial and final B P.R.S. scores. 
There was no difference in the out-
come between male and female patients. 
Discussion 
In this study, 5 (20.8%) patients had 
a dysphoric response to the test dose and 
19 (79.2%) had a syntonic response. The 
dysphoric and syntonic patients did not 
differ with respect to age, duration of ill-
ness, severity of psychopathology or sex 
distribution—(Table I). However, the 
improvement with drug treatment was 
significantly less in the dysphoric group. 
Furthermore, the correlation between the 
subjective response scores and the change 
in B.P.R.S. scores for the whole sample 
was highly significant (r«=0.57, p<0.005, 
n=24). This indicate a very strong 
relationship between a positive response 
to the test dose and clinical improvement. 
Toe only other significant correlation was 
between the length of illness and improve-
ment, a longer duration of illness being 
associated with a poorer outcome (r =» 
-0.36, p<0.05). 
It is interesting that the most signifi-
cant predictor of poor outcome in this 
study was found to be a dysphoric response 
to the test dose. The findings of this 
study are similar to those of earlier studies 
in the Western literature (Van Putten 
and May, 1978; Hoganetal., 1985;Bartko 
etal., 1987). The subjective response 
could not be predicted on the basis of 
clinical and demographic variables, and 
it was not related to the severity of psy-
chopathology (Initial B.P.R.S. scores). A 
dysphoric response was strongly associated 
with a poor outcome. 
The relationship between the subjec-
tive response and the improvement with 
treatment has been shown to be indepen-
dent of the type of neuroleptis used. 
Similar findings have been reported with 
haloperidol (Singh and Smith, 1973; 
Bartko et al., 1987) and with chloropro-
mazine or thiothixene (Van Putten et al., 
1980a). No correlation has been found 
between the plasma level of the drug and 
the subjective response (Van Putten et al., 
1980b). 
Van Putten et al. (1981) reported an 
association between dysphoric responses PREDICTION OF OUTCOME IN SCHIZOPHRENIA  61 
and later development of extrapyramidal 
side effects of neuroleptics. However these 
findings were not confirmed by Hogan 
ct al. (1985). The subjective responses 
appears to be an idiosyncratic phenome-
non, due to either altered receptor sensiti-
vity or a patient's personal interpretation 
of the effects of the drug (Van Putten 
ct al., 1980b). 
We ask schizophrenic patients many 
questions but we rarely ask them whether 
their medication agrees with them. This 
study suggests that we could learn a lot 
from their answer to this simple question. 
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